Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
pleckstrin homology and RUN domain containing M1 | 0.691 | 0.577 | 8.1E-03 |
|
disease | 0.800 | limited | 1.000 | 1 | 0 | 2007 | 2016 | ||||||||
|
fibulin 5 | 0.546 | 0.692 | 1.00 |
|
disease | 0.700 | limited | 1.000 | 0 | 0 | 2002 | 2018 | ||||||||
|
cytochrome b-245 beta chain | 0.452 | 0.885 | 1.00 |
|
group | 0.900 | limited | 0.986 | 0 | 0 | 1987 | 2020 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.800 | limited | 1.000 | 0 | 0 | 1998 | 2019 | ||||||||
|
dynamin 2 | 0.542 | 0.769 | 1.00 |
|
disease | 0.900 | limited | 0.982 | 0 | 0 | 2005 | 2019 | ||||||||
|
spectrin repeat containing nuclear envelope protein 1 | 0.511 | 0.846 | 3.2E-52 |
|
disease | 0.770 | limited | 1.000 | 0 | 0 | 2007 | 2019 | ||||||||
|
EGF containing fibulin extracellular matrix protein 2 | 0.559 | 0.692 | 8.2E-03 |
|
disease | 0.650 | limited | 1.000 | 0 | 0 | 2010 | 2016 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 1.000 | limited | 0.981 | 0 | 0 | 1975 | 2019 | ||||||||
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
disease | 1.000 | limited | 0.896 | 0 | 0 | 1996 | 2020 | ||||||||
|
rhodopsin | 0.525 | 0.769 | 1.3E-04 |
|
disease | 0.900 | limited | 1.000 | 0 | 0 | 1993 | 2011 | ||||||||
|
valosin containing protein | 0.469 | 0.923 | 1.00 |
|
disease | 0.900 | limited | 1.000 | 0 | 0 | 2004 | 2019 | ||||||||
|
latent transforming growth factor beta binding protein 4 | 0.604 | 0.654 | 0.50 |
|
disease | 0.600 | limited | 1.000 | 0 | 0 | 2013 | 2013 | ||||||||
|
period circadian regulator 2 | 0.488 | 0.846 | 0.71 |
|
disease | 0.800 | limited | 1.000 | 0 | 0 | 2001 | 2001 | ||||||||
|
EF-hand domain containing 1 | 0.659 | 0.231 | 1.9E-17 |
|
disease | 1.000 | disputed | 0.979 | 1 | 0 | 1993 | 2019 | ||||||||
|
sodium voltage-gated channel beta subunit 3 | 0.686 | 0.269 | 5.1E-02 |
|
phenotype | 0.500 | disputed | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 3 | 0.686 | 0.269 | 5.1E-02 |
|
phenotype | 0.500 | disputed | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 3 | 0.686 | 0.269 | 5.1E-02 |
|
disease | 0.500 | disputed | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 3 | 0.686 | 0.269 | 5.1E-02 |
|
disease | 0.530 | disputed | 0.917 | 1 | 0 | 2001 | 2016 | ||||||||
|
sodium voltage-gated channel beta subunit 3 | 0.686 | 0.269 | 5.1E-02 |
|
phenotype | 0.500 | disputed | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
carboxypeptidase E | 0.584 | 0.692 | 0.99 |
|
disease | 0.730 | moderate | 0.923 | 8 | 0 | 1991 | 2013 | ||||||||
|
gap junction protein beta 6 | 0.528 | 0.808 | 1.7E-07 |
|
disease | 0.800 | moderate | 1.000 | 5 | 0 | 1998 | 2016 | ||||||||
|
endothelin receptor type B | 0.470 | 0.846 | 9.2E-03 |
|
disease | 1.000 | moderate | 1.000 | 4 | 0 | 1994 | 2018 | ||||||||
|
granulin precursor | 0.435 | 0.846 | 7.0E-02 |
|
disease | 0.980 | moderate | 1.000 | 4 | 0 | 2006 | 2018 | ||||||||
|
glycine receptor alpha 1 | 0.628 | 0.500 | 1.6E-04 |
|
phenotype | 0.700 | moderate | 0.979 | 3 | 0 | 1992 | 2019 | ||||||||
|
HR lysine demethylase and nuclear receptor corepressor | 0.722 | 0.192 | 7.4E-10 |
|
disease | 0.900 | moderate | 1.000 | 3 | 0 | 1998 | 2014 |